Cover Image
市場調查報告書

醫療外包的全球市場:各類型 (醫療費申請,醫療提供者取向,醫藥,病理分析、檢驗)、各地區的未來預測

Healthcare Outsourcing Market : By Type (Healthcare Payer and Provider, Pharmaceutical, Pathology and Labs); By Region & By Geography - Forecast (2016-2021)

出版商 IndustryARC 商品編碼 385571
出版日期 內容資訊 英文 241 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫療外包的全球市場:各類型 (醫療費申請,醫療提供者取向,醫藥,病理分析、檢驗)、各地區的未來預測 Healthcare Outsourcing Market : By Type (Healthcare Payer and Provider, Pharmaceutical, Pathology and Labs); By Region & By Geography - Forecast (2016-2021)
出版日期: 2016年07月12日 內容資訊: 英文 241 Pages
簡介

本報告提供全球醫療產業取向外包的市場相關分析,整體市場結構,及主要推動及阻礙市場要素,市場競爭概況,近來的資本交易、策略發展的動向,服務的各類型、各技術、各地區的市場趨勢預測 (今後6年份),關於主要企業簡介等調查評估。

第1章 醫療外包:市場概要

第2章 摘要整理

第3章 醫療外包:市場環境

  • 市場佔有率分析
  • 比較分析
    • 產品比較分析
    • 前五名公司的財務分析

第4章 醫療外包:市場影響要素

  • 市場推動因素
  • 市場阻礙因素、課題
  • 市場課題
  • 醫療外包產業的向心力

第5章 醫療外包市場:策略分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 產品/市場生命週期分析
  • 供應商、經銷商

第6章 醫療外包市場:服務的各類型

  • 醫療費申請業務外包
    • 醫療費申請處理
    • 醫療費申請判斷
  • 醫療事務外包
    • 基因改造肽
    • 郵件處理服務
    • 人事 (HR) 服務
    • 顧客關懷服務
    • 其他
  • 醫療提供者取向業務
    • 職員採用
    • 醫生採用
    • 醫療費申請
    • 醫療記錄 (病歷) 作成
    • 醫療資料作成
    • 財務、會計
    • 其他
  • 藥理外包 (臨床)
    • 藥物研發、開發
    • 臨床試驗前
    • 臨床實驗
    • 分析實驗
    • 原料藥 (API)開發
    • 劑型、包裝
    • 其他
  • 藥理外包 (非臨床)
    • 供應鏈管理 (SCM)、物流
    • 銷售、行銷
    • 其他
  • 病理分析、檢驗外包
    • 醫療記錄管理
    • 品管服務
    • SCM、物流
    • 其他

第7章 醫療外包市場:各技術

  • 單株抗體技術
  • 基因改造DNA技術
  • 層析法
  • 核磁共振 (NMR) 技術
  • 電泳
  • 質譜分析
  • 西方墨點法
  • 生物審定 (生物檢測)

第8章 醫療外包市場:各地區

  • 南北美洲 (美國,加拿大,墨西哥,南美等)
  • 歐洲 (英國,法國,德國,義大利等)
  • 亞太地區 (中國,日本,印度,韓國等)
  • 其他的國家 (RoW)

第9章 投資機會分析

第10章 市場最新形勢

  • 新產品的銷售
  • 企業合併、收購 (M&A),產業聯盟,合資企業,產業合作

第11章 企業簡介

  • Firstsource Solutions Ltd
  • Accretive Health
  • ICON plc
  • Patheon Inc
  • Hexaware Technologies Ltd
  • IBM Corporation
  • IDS Infotech Ltd
  • Infosys Limited
  • Omega Healthcare
  • WNS Global Services Ltd.
  • Sun Knowledge Limited
  • Tata Consultancy Services Limited
  • Tech Mahindra Limited
  • Wipro Limited
  • Siemens AG Company
  • Cognizant Technology Solutions
  • inVentiv Health, Inc.
  • Boehringer Ingelheim GmbH
  • CAPGEMINI GROUP.
  • Accenture LLP
  • QUINTILES, INC
  • GeBBs Healthcare Solutions, Inc

第12章 附錄

目錄

Healthcare centres such as hospitals have been outsourcing various ancillary tasks globally. Outsourcing enables hospitals to focus on their core task of providing efficient healthcare services. Outsourcing ancillary processes can improve the financial results by reducing administrative costs and increasing revenues, efficiency and service quality. In hospitals, most of the ancillary activities require specialized skills or require substantial infrastructure. Growing number of hospitals, clinics, research institutes, pharmaceutical/clinical laboratories along with significant growth in pharmaceutical industry are driving the healthcare outsourcing market. There are different manufacturers who deliver Healthcare/Medical Outsourcing types of products payer outsourcing services, provider outsourcing services, pharmaceutical outsourcing services and pathology and laboratory outsourcing services.

The developing need of healthcare outsourcing is mainly because of the promptly growing cost of healthcare services and the cost of government healthcare programs has moved to healthcare sources which ultimately lead to healthcare providers receiving less advantage for their amenities and they are facing more encumbrances from patients to continue to deliver superior care. In response to this, healthcare service providers are looking for outsourcing way out to combat these rising expenses. Wide range of service providers operate in the market which have the required infrastructure and skilled resources to process healthcare claims adjudication services on any scale and streamline the verification and claims adjudication process. Pharmaceutical is anticipated to dominate the global healthcare outsourcing market by services and is estimated to control around 65% of the total healthcare outsourcing market revenue by services in 2021. However, payer is estimated to attain the fastest growth rate during the forecast period.

Many new multi-specialty hospitals chains have come up, which are driving the need for outsourcing. Moreover, Hospitals have started to use third party services for interpretation of imaging results or transcription of physician's case notes which is all set to create a boom in the healthcare outsourcing market. The healthcare outsourcing market is driven by increasing number of service providers which include payer, healthcare operations, healthcare providers, pharma outsourcing, pathology & lab outsourcing and many others. Outsourcing drug development and clinical trials, enables companies to focus on core capabilities. This is yet other reasons which will drive the growth of healthcare outsourcing in the near future.

The report analyses the healthcare outsourcing market demand with respect to various regions. Competitive landscape for top five healthcare outsourcing markets is highlighted and market players are profiled and are analysed on disparate aspects like company overview, financial overview, product portfolio and recent developments.

Healthcare Outsourcing Market Classification:

  • Payer Outsourcing
  • Healthcare Operations Outsourcing
  • Healthcare Provider
  • Pharma Outsourcing (Clinical)
  • Pharma Outsourcing (Non-Clinical)
  • Pathology and Lab Outsourcing

Table of Contents

1. Healthcare Outsourcing - Market Overview

2. Executive Summary

3. Healthcare Outsourcing - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Patent Analysis
  • 3.3. Comparative Analysis
    • 3.3.1. Competitive Benchmarking
    • 3.3.2. Top 5 Financials Analysis

4. Healthcare Outsourcing - Market Forces

  • 4.1. Market Drivers
    • 4.1.1. Many new multi-specialty hospitals chains have come up, which are driving the need for outsourcing
    • 4.1.2. Services related to care management and healthcare plan development, channel management and risk assessment among others are in demand
    • 4.1.3. Demand from other regions in APAC and Europe who are also looking out for outsourcing vendors
    • 4.1.4. Hospitals have started to use third party services for interpretation of imaging results or transcription of physician's case notes
    • 4.1.5. Need for structures process and better medical record management
    • 4.1.6. Outsourcing drug development and clinical trials, enables companies to focus on core capabilities
  • 4.2. Market Constraints and Challenges
    • 4.2.1. The provider market is very fragmented with very few hospital chains having the scale to turn to outsourcing
    • 4.2.2. Specialist hospital management companies to compete with BPO companies
    • 4.2.3. Lack of adequate infrastructure for pre-clinical studies
    • 4.2.4. IPR protection apprehensions while outsourcing
    • 4.2.5. Availability of skilled labor while outsourcing medical imaging or similar services
  • 4.3. Attractiveness of the Healthcare Outsourcing Industry
    • 4.3.1. Power of Suppliers
    • 4.3.2. Power of Customers
    • 4.3.3. Threat of New entrants
    • 4.3.4. Threat of Substitution
    • 4.3.5. Degree of Competition

5. Healthcare Outsourcing Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Product/Market Life Cycle Analysis
  • 5.4. Opportunities Analysis
  • 5.5. Suppliers and Distributors

6. Healthcare Outsourcing Market: By Type of Services

  • 6.1. Payer Outsourcing
    • 6.1.1. Claims Processing
    • 6.1.2. Claims adjudication
  • 6.2. Healthcare Operations Outsourcing
    • 6.2.1. Recombinant Peptides Others
    • 6.2.2. Mailroom services
    • 6.2.3. HR Services
    • 6.2.4. Customer Care Services
    • 6.2.5. Others
  • 6.3. Healthcare Provider
    • 6.3.1. Member Enrolment
    • 6.3.2. Physician Enrolment
    • 6.3.3. Medical Billing
    • 6.3.4. Medical Coding
    • 6.3.5. Medical Transcription
    • 6.3.6. Finance & Accounts
    • 6.3.7. Others
  • 6.4. Pharma Outsourcing (Clinical)
    • 6.4.1. Drug Discovery and Development
    • 6.4.2. Pre-Clinical Testing
    • 6.4.3. Clinical Trial
    • 6.4.4. Analytical Testing
    • 6.4.5. API Development
    • 6.4.6. Formulation & Packaging
    • 6.4.7. Others
  • 6.5. Pharma Outsourcing (Non-Clinical)
    • 6.5.1. SCM & Logistics
    • 6.5.2. Sales & Marketing
    • 6.5.3. Others
  • 6.6. Pathology and Lab Outsourcing
    • 6.6.1. Records Maintenance
    • 6.6.2. Quality Control Service
    • 6.6.3. SCM & Logistics
    • 6.6.4. Others

7. Healthcare Outsourcing Market - By Technology

  • 7.1. Monoclonal Antibodies Technology
  • 7.2. Recombinant DNA Technology
  • 7.3. Chromatography
  • 7.4. Nuclear Magnetic Resonance Technology
  • 7.5. Electrophoresis
  • 7.6. Mass Spectrometry
  • 7.7. Western Blotting
  • 7.8. Bioassay

8. Healthcare Outsourcing Market -Geographic Analysis

  • 8.1. Americas
    • 8.1.1. US
    • 8.1.2. Canada
    • 8.1.3. Mexico
    • 8.1.4. Latin America
    • 8.1.5. Others
  • 8.2. Europe
    • 8.2.1. UK
    • 8.2.2. France
    • 8.2.3. Germany
    • 8.2.4. Italy
    • 8.2.5. Others
  • 8.3. APAC
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. South Korea
    • 8.3.5. Others
  • 8.4. ROW

9. Investment Opportunities Analysis

10. Market Entropy

  • 10.1. New Product Launches
  • 10.2. M&As, Collaborations, JVs and Partnerships

11. Company Profiles

  • 11.1. Firstsource Solutions Ltd
  • 11.2. Accretive Health
  • 11.3. ICON plc
  • 11.4. Patheon Inc
  • 11.5. Hexaware Technologies Ltd
  • 11.6. IBM Corporation
  • 11.7. IDS Infotech Ltd
  • 11.8. Infosys Limited
  • 11.9. Omega Healthcare
  • 11.10. WNS Global Services Ltd.
  • 11.11. Sun Knowledge Limited
  • 11.12. Tata Consultancy Services Limited
  • 11.13. Tech Mahindra Limited
  • 11.14. Wipro Limited
  • 11.15. Siemens AG Company
  • 11.16. Cognizant Technology Solutions
  • 11.17. inVentiv Health, Inc.
  • 11.18. Boehringer Ingelheim GmbH
  • 11.19. CAPGEMINI GROUP.
  • 11.20. Accenture LLP
  • 11.21. QUINTILES, INC
  • 11.22. GeBBs Healthcare Solutions, Inc

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top